Immediately discontinue administration if signs & symptoms of a clinically significant hypersensitivity reaction or anaphylaxis occur. Consider risks & benefits prior to administration in individuals at high risk for CV or thrombo-embolic events. Give w/ caution to patients w/ thrombocytopenia or any coagulation disorder. Risk of antiviral resistance. Not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended. Pregnancy. Safety & efficacy in childn <12 yr have not yet been established.
The product is conditionally approved with limited safety, efficacy, and quality data for public health emergency to satisfy local unmet medical need and the registration status is subjected to be reviewed by the Pharmacy and Poisons (Registration of Pharmaceutical Products and Substances: Certification of Clinical Trial/Medicinal Test) Committee. The product can only be supplied to institutions or registered medical practitioners. (Drug Office, Department of Health HK)
Presentation/Packing
Form
Evusheld soln for inj 150 mg/1.5 mL + 150 mg/1.5 mL
Packing/Price
2's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
